Sponsored content

Stefanie Parchmann of Maiwald considers the long-awaited referral to the Enlarged Board of Appeal regarding plausibility

Dr Gisela Grabow of Maiwald explains the importance of a comprehensive approach to the revision of pharmaceutical legislation that considers the relationship with IP rights and the Action Plan on IP

Chris de Mauny of Bird & Bird discusses the current and future importance of sufficiency in light of recent UK case law

Yan Zhang and Lin Mu of Lifang & Partners discuss a Supreme People’s Court case that establishes the timeframe for damages awarded to trademark owners

Aysel Korkmaz Yatkin and Aysu Eryaşar of Gun and Partners evaluate the position of Turkey’s IP courts in a case focusing on preliminary injunction assessments

Xiaoming Zhang and Haitao Li of Liu Shen & Associates describe how two cutting-edge technologies, 5G and artificial intelligence, are empowering each other

Jeremy Dobbin of FB Rice summarises the key changes implemented by the Design Amendment (Advisory Council on Intellectual Property Response) Act 2021 and advises when they take effect

Min Son of Hanol IP & Law looks at the alternatives available when South Korea does not acknowledge safeguards for missing deadlines as provided in the WIPO’s Patent Cooperation Treaty rules

Margaret Le Galle of Spoor & Fisher explains why the Plant Variety Protection Act 2021 will bring Nigerian IP law in line with international norms

Francis Declercq of Cabinet Beau de Loménie looks at the key tax changes arising from the IP box regime in France

Rachna Bakhru of RNA Technology and IP Attorneys explains the urgent need for clear regulations surrounding cryptocurrencies and NFTs in India

CA Brijesh and Shubham Shende of Remfry & Sagar describe why the Indian courts seem to be taking a more lenient view of comparative advertising